1 |
Saleh E, Ukwas A. Adenoid cystic carcinoma of salivary glands: a ten-year review and an assessment of the current management, surgery, radiotherapy, and chemotherapy[J]. Int J Otolaryngol, 2023, 2023: 7401458.
|
2 |
Fang Y, Peng Z, Wang Y, et al. Current opinions on diagnosis and treatment of adenoid cystic carcinoma[J]. Oral Oncol, 2022, 130: 105945.
|
3 |
Thomas P, Pranatharthi A, Ross C, et al. RhoC: a fascinating journey from a cytoskeletal organizer to a cancer stem cell therapeutic target[J]. J Exp Clin Cancer Res, 2019, 38(1): 328.
|
4 |
Lou Y, Jiang Y, Liang Z, et al. Role of RhoC in cancer cell migration[J]. Cancer Cell Int, 2021, 21(1): 527.
|
5 |
Hu Y, Liu H, Zhu Z, et al. LACTB suppresses migration and invasion of glioblastoma via downregulating RH-OC/Cofilin signaling pathway[J]. Biochem Biophys Res Commun, 2022, 629: 17-25.
|
6 |
Ghafouri-Fard S, Noroozi R, Abak A, et al. Emerging role of lncRNAs in the regulation of Rho GTPase pathway[J]. Biomed Pharmacother, 2021, 140: 111731.
|
7 |
迟增鹏, 周建华, 李文健, 等. 沉默RhoA基因对腺样囊性癌细胞迁移和侵袭的影响[J]. 口腔疾病防治, 2022, 30(4): 237-244.
|
|
Chi ZP, Zhou JH, Li WJ, et al. Effects of RhoA silencing on the migration and invasion of salivary adenoid cystic carcinoma[J]. J Prevent Treat Stomatol Dis, 2022, 30(4): 237-244.
|
8 |
da Silva FJ, Carvalho de Azevedo J Jr, Ralph ACL, et al. Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications[J]. Front Oncol, 2023, 13: 1191218.
|
9 |
Hoch CC, Stögbauer F, Wollenberg B. Unraveling the role of epithelial-mesenchymal transition in adenoid cystic carcinoma of the salivary glands: a comprehensive review[J]. Cancers (Basel), 2023, 15(11): 2886.
|
10 |
Smithers CC, Overduin M. Structural mechanisms and drug discovery prospects of Rho GTPases[J]. Cells, 2016, 5(2): 26.
|
11 |
Rodenburg WS, van Buul JD. Rho GTPase signalling networks in cancer cell transendothelial migration[J]. Va-sc Biol, 2021, 3(1): 77-95.
|
12 |
Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC[J]. Nature, 2000, 406(6795): 532-535.
|
13 |
Morgan-Fisher M, Wewer UM, Yoneda A. Regulation of ROCK activity in cancer[J]. J Histochem Cytochem, 2013, 61(3): 185-198.
|
14 |
Kim S, Kim SA, Han J, et al. Rho-Kinase as a target for cancer therapy and its immunotherapeutic potential[J]. Int J Mol Sci, 2021, 22(23): 12916.
|
15 |
Roche O, Fernández-Aroca DM, Arconada-Luque E, et al. p38β and cancer: the beginning of the road[J]. Int J Mol Sci, 2020, 21(20):7524.
|
16 |
Han J, Wu J, Silke J. An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling[J]. F1000Res, 2020, 9: 653.
|
17 |
Bagrodia S, Dérijard B, Davis RJ, et al. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation[J]. J Biol Chem, 1995, 270(47): 27995-27998.
|
18 |
Razzaque MS, Atfi A. Regulatory role of the transcription factor Twist1 in cancer-associated muscle cachexia[J]. Front Physiol, 2020, 23, 11: 662.
|
19 |
Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression[J]. Br J Cancer, 2006, 94(1): 13-17.
|
20 |
Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications[J]. Mol Cancer, 2016, 15: 18.
|
21 |
Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell, 2004, 117(7): 927-939.
|
22 |
Thiery JP. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2(6): 442-454.
|
23 |
Tang YF, Wu WJ, Zhang JY, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland[J]. Transl Cancer Res, 2021, 10(12): 5133-5149.
|